Surgical treatment of nasal non-melanoma skin cancer in elderly patients using dermal substitute

Conclusions: The nose is often involved by non-melanoma skin cancer (NMSC) and the increase in the incidence of such tumors, the morbidity and treatment-related costs represent a significant burden to healthcare systems. A bioresorbable dermal substitute (Hyalomatrix ® ) has been used for immediate...

Full description

Saved in:
Bibliographic Details
Published inActa oto-laryngologica Vol. 136; no. 12; pp. 1299 - 1303
Main Authors Dessy, Luca Andrea, Marcasciano, Marco, Fanelli, Benedetta, Mazzocchi, Marco, Ribuffo, Diego
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.12.2016
Subjects
Aged
Basal cell carcinoma
Carcinoma, Basal Cell - surgery
Carcinoma, Squamous Cell - surgery
critical patients
Female
Humans
hyalomatrix
Male
nasal neoplasms
Prospective Studies
skin cancer
Skin Neoplasms - surgery
Skin, Artificial
squamous cell carcinoma
critical patients
nasal neoplasms
skin cancer
hyalomatrix
Basal cell carcinoma
squamous cell carcinoma
Online AccessGet full text

Cover

More Information
Summary:Conclusions: The nose is often involved by non-melanoma skin cancer (NMSC) and the increase in the incidence of such tumors, the morbidity and treatment-related costs represent a significant burden to healthcare systems. A bioresorbable dermal substitute (Hyalomatrix ® ) has been used for immediate dermal coverage and nose restoration after excision of infiltrating nasal NMSCs in elderly ASA III patients. Further studies on dermal substitutes are needed to improve benefit to patients. Objective: Surgical treatment of nasal non-melanoma skin cancer (NMSC) in elderly patients. Materials and methods: Ten elderly ASA III patients with nasal defects after resection of infiltrating NMSC were reconstructed in a two-stage strategy. The surgical protocol targeted an initial wide tumor excision and apposition of a dermal induction template (Hyalomatrix ® ) and successive full thickness skin autograft. Results were documented by photography, visual analog scale for patient satisfaction, and Vancouver scar scale for evaluation of final graft characteristics. Results: All patients were tumor-free during the 2 years follow-up. The procedure achieved acceptable nose reshaping and graft scarring evolution. Patient satisfaction was good-to-high.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0001-6489
1651-2251
DOI:10.1080/00016489.2016.1205221